Saudi Oncology Society clinical management guidelines for urinary bladder cancer. - Wikidata - wikimedia - TriplyDB

Saudi Oncology Society clinical management guidelines for urinary bladder cancer.

Saudi Oncology Society clinical management guidelines for urinary bladder cancer.

http://www.wikidata.org/entity/Q34997367

about

Saudi Oncology Society clinical management guidelines for urinary bladder cancer.

http://www.wikidata.org/entity/Q34997367

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Saudi Oncology Society clinical management guidelines for urinary bladder cancer.

@ast

Saudi Oncology Society clinical management guidelines for urinary bladder cancer.

@en

Saudi Oncology Society clinical management guidelines for urinary bladder cancer.

@nl

type

label

Saudi Oncology Society clinical management guidelines for urinary bladder cancer.

@ast

Saudi Oncology Society clinical management guidelines for urinary bladder cancer.

@en

Saudi Oncology Society clinical management guidelines for urinary bladder cancer.

@nl

prefLabel

Saudi Oncology Society clinical management guidelines for urinary bladder cancer.

@ast

Saudi Oncology Society clinical management guidelines for urinary bladder cancer.

@en

Saudi Oncology Society clinical management guidelines for urinary bladder cancer.

@nl

P1433

Q34997367-69433FC3-061B-436A-8198-4D0D0EE0A243

P1476

Q34997367-B596D24C-78EB-464A-B93E-4236CDDB4506

P2093

Q34997367-78DE8ED4-C78D-4535-ADA8-F39F365DA202

Q34997367-7C47EC6F-7AEF-4181-80F9-01CC1A2CE889

Q34997367-82678DDF-8059-4B99-908F-1C86D3BE9194

Q34997367-9EE3F260-BE09-49EE-BE22-7BA6D28351DE

Q34997367-A345D8D5-59BC-47F3-8B19-6FB77CF5C507

Q34997367-A507BAED-AC04-4016-B616-94DD9E19181E

Q34997367-B79C71FC-823B-4965-865F-6812F25A76EA

Q34997367-C32F7420-225D-4510-A3CE-7252537193C5

Q34997367-CC084375-B085-4A23-9F8B-10C68A17A352

Q34997367-EC14CC3D-7417-4FD8-8E42-800C47816AAE

P2860

Q34997367-14AEE25B-FB3E-4025-BF47-8F6496105FEB

Q34997367-2C45FABA-4050-4D1F-8749-37471DE4B541

Q34997367-41941321-2635-47EF-A1C9-68F21C28611C

Q34997367-45640840-7409-483A-AB07-30CD6EF57BF0

Q34997367-48534A97-2F0F-496D-8B4D-6C3539D84B3A

Q34997367-4AE02189-AC4F-4E37-9DA1-4BA3DBD5A077

Q34997367-6B2CB80F-A73F-496C-8F3E-443B82607805

Q34997367-7F15F406-90A4-4EFF-BBA8-2C5E2F59EFA2

Q34997367-801B4385-5846-43AE-AA65-A882FF9858F8

Q34997367-8DCB360F-483B-4D67-811B-54940C6F47B3

P304

Q34997367-01F11789-B883-4B7D-899B-C5C4D6B5F3A4

P31

Q34997367-DB86CAD6-6C3E-4815-A64F-70F3B3C199C4

P356

Q34997367-40FBB6D3-ECC4-45F2-A3EC-EC48A45856AB

P478

Q34997367-B7803DD1-A058-482A-8D59-08C323AC0868

P50

Q34997367-90522F3F-B046-4944-AC9F-465F259B2BCC

P577

Q34997367-3914ECEF-4C7E-4CC2-BEB2-51A53E159606

P5875

Q34997367-C2311334-5943-4991-8F7B-FD49DA991805

P698

Q34997367-1A078F39-E304-4E79-AF1A-D06E4CE09719

P932

Q34997367-576ACEB3-8CF0-491F-81B7-2D45A4D9206B

P356

0974-7796.78549

P1433

P1476

Saudi Oncology Society clinical management guidelines for urinary bladder cancer

@en

P2093

Ahmad Salah

http://www.w3.org/2001/XMLSchema#string

Ali Jubran

http://www.w3.org/2001/XMLSchema#string

Baher Kamal

http://www.w3.org/2001/XMLSchema#string

Eyad Al Saeed

http://www.w3.org/2001/XMLSchema#string

Ibraheem Al Oraifi

http://www.w3.org/2001/XMLSchema#string

Jalal Al Shareef

http://www.w3.org/2001/XMLSchema#string

Jamal Zekri

http://www.w3.org/2001/XMLSchema#string

Khaled Al Othman

http://www.w3.org/2001/XMLSchema#string

Khalid Al Gamdi

http://www.w3.org/2001/XMLSchema#string

Khalid Balaraj

http://www.w3.org/2001/XMLSchema#string

P2860

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis.

EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ.

Management of stage T1 tumors of the bladder: International Consensus Panel.

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

Transitional cell carcinoma of the prostate.

Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.

A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials.

Bladder cancer: epidemiology, staging and grading, and diagnosis.

P304

S6-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0974-7796.78549

http://www.w3.org/2001/XMLSchema#string

P478

3 Suppl

http://www.w3.org/2001/XMLSchema#string

P50

Shouki Bazarbashi

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51219841

http://www.w3.org/2001/XMLSchema#string

P698

21673850

http://www.w3.org/2001/XMLSchema#string

P932

3099485

http://www.w3.org/2001/XMLSchema#string